FUKOKU MUTUAL LIFE INSURANCE Co Purchases 1,000 Shares of CME Group Inc. (NASDAQ:CME)

FUKOKU MUTUAL LIFE INSURANCE Co boosted its position in CME Group Inc. (NASDAQ:CME) by 30.8% during the 3rd quarter, Holdings Channel reports. The fund owned 4,242 shares of the financial services provider’s stock after buying an additional 1,000 shares during the period. FUKOKU MUTUAL LIFE INSURANCE Co’s holdings in CME Group were worth $936,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of CME. Capital International Investors boosted its position in CME Group by 24.1% during the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after buying an additional 3,069,806 shares during the period. PineStone Asset Management Inc. boosted its position in shares of CME Group by 137.6% in the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after purchasing an additional 1,309,097 shares during the period. M&G Plc purchased a new stake in CME Group during the 1st quarter valued at approximately $156,631,000. Assenagon Asset Management S.A. lifted its holdings in shares of CME Group by 577.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock valued at $126,872,000 after acquiring an additional 550,133 shares during the last quarter. Finally, Ameriprise Financial Inc. boosted its holdings in shares of CME Group by 11.3% in the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after purchasing an additional 537,758 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 12.01 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Timothy S. Bitsberger sold 1,000 shares of CME Group stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total transaction of $226,960.00. Following the sale, the director now owns 10,589 shares in the company, valued at approximately $2,403,279.44. The trade was a 8.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock valued at $3,441,063 in the last 90 days. 0.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research firms have recently commented on CME. Redburn Atlantic downgraded shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a report on Tuesday, October 8th. Royal Bank of Canada reissued a “sector perform” rating and issued a $235.00 target price on shares of CME Group in a report on Thursday, October 24th. Barclays lifted their price objective on shares of CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research report on Thursday, October 24th. Keefe, Bruyette & Woods boosted their price target on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Finally, TD Cowen initiated coverage on shares of CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective for the company. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus target price of $224.47.

CME Group Stock Performance

Shares of CME opened at $223.42 on Friday. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $230.36. The stock has a 50 day moving average price of $222.44 and a 200 day moving average price of $210.17. The company has a market capitalization of $80.45 billion, a price-to-earnings ratio of 23.49, a price-to-earnings-growth ratio of 5.26 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the prior year, the company posted $2.25 earnings per share. Research analysts predict that CME Group Inc. will post 10.23 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.06%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s payout ratio is 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.